Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 640.92M | 775.34M | 672.58M | 565.27M | 506.95M |
| Total Receivables | 108.22M | 96.79M | 100.65M | 92.98M | 105.97M |
| Inventory | 5.28M | 5.36M | 6.88M | 6.10M | 6.38M |
| Prepaid Expenses | 16.80M | 16.01M | 23.31M | 18.36M | 16.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.60M | 13.52M | 35.38M | 8.64M | 6.92M |
| Total Current Assets | 778.82M | 907.01M | 838.80M | 691.35M | 642.69M |
|
|
|||||
| Total Current Assets | 778.82M | 907.01M | 838.80M | 691.35M | 642.69M |
| Net Property, Plant & Equipment | 5.39M | 5.34M | 2.67M | 2.65M | 3.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 83.46M | 89.42M | 95.38M | 101.34M | 107.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 174.61M | 162.73M | 165.54M | 205.65M | 199.19M |
| Total Assets | 1.27B | 1.27B | 1.21B | 1.11B | 1.06B |
|
|
|||||
| Total Accounts Payable | 28.60M | 17.69M | 26.34M | 28.30M | 17.46M |
| Total Accrued Expenses | 156.83M | 209.48M | 161.24M | 130.03M | 120.28M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.27M | 21.07M | 20.83M | 19.60M | 18.65M |
| Total Finance Division Other Current Liabilities | 10.64M | 3.88M | 15.00M | 2.21M | 18.73M |
| Total Other Current Liabilities | 10.64M | 3.88M | 15.00M | 2.21M | 18.73M |
| Total Current Liabilities | 217.34M | 252.13M | 223.40M | 180.14M | 175.12M |
|
|
|||||
| Total Current Liabilities | 217.34M | 252.13M | 223.40M | 180.14M | 175.12M |
| Long-Term Debt | 138.81M | 143.66M | 148.51M | 153.35M | 158.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.53M | 4.51M | 403.00K | 432.00K | 634.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 793.00K | 1.11M | 783.00K | 1.02M | 1.08M |
| Total Liabilities | 361.48M | 401.41M | 373.10M | 334.93M | 335.01M |
|
|
|||||
| Common Stock & APIC | 717.37M | 708.97M | 696.35M | 685.29M | 672.50M |
| Retained Earnings | 193.39M | 160.90M | 138.42M | 87.55M | 47.78M |
| Treasury Stock & Other | -413.00K | 346.00K | 357.00K | 239.00K | 245.00K |
| Total Common Equity | 910.35M | 870.22M | 835.12M | 773.08M | 720.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 910.35M | 870.22M | 835.12M | 773.08M | 720.53M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 910.35M | 870.22M | 835.12M | 773.08M | 720.53M |
|
|
|||||